Agilex Biolabs announces 40% growth in 2019 at OCT New England
Boston, MA - Agilex Biolabs, the Asia Pacific’s leading bioanalytical laboratory, announced at “OCT New England”a 40% growth for 2019. (2-3 October 2019 Boston, MA - Agilex Biolabs Booth #12) The 40% growth was largely from US and Asia pharmaceutical and biotechnology...
Agilex Biolabs at OCT Southern California
BioPharma Press | Agilex Biolabs announced analysis of more than 60 thousand pre-clinical, as well as, clinical trials in this year
The pioneering bioanalytical laboratory of Australia for clients all over the world conducting pre-clinical, as well as, clinical trials, Agilex Biolabs, has made an announcement this week at DIA that it will be analyzing over a 60K samples in this year. Agilex...
Agilex Biolabs at DIA: on track for more than 60,000 clinical trial sample analysis in 2019
Read the full press announcement here
Agilex Biolabs now offering cannabinoid metabolite analysis by LC-MS/MS
We are excited to now offer a robust and fully validated multiplex Cannabinoid assay in human plasma and are currently running sample analysis of our clients’ medical cannabis studies. Tom Midgley, Study Director, Immunoassay, performing sample analysis. Our multiplex...
Please fill in this form and we will be in contact shortly: